Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,091,082
+$715,204 QoQ
Shares Held
2,032
+63.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#189
of 411 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Dec 31, 2024CallValue
$617,140
CallShares
2,000
PutValue
$2,314,275
PutShares
7,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. MDGL ranks #33 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
134,214 | $40,402,439 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
223,995 | $21,835,032 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,306 | $13,908,683 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
347,106 | $10,850,533 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
5,112,098 | $8,521,240 | |
| 6 | ARGX |
Argenx SE
|
8,200 | $7,607,714 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
150,200 | $7,065,408 | |
| 8 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 |
All Filings in MDGL
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,091,082 | 2,032 | Shares | Other | 2026-08-14 | |
| 2025-06-30 | $375,878 | 1,242 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $411,386 | 1,242 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $617,140 | 2,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $2,314,275 | 7,500 | Put | Sole | 2025-02-14 | |
| 2024-06-30 | $476,272 | 1,700 | Call | Other | 2024-08-14 | |
| 2024-03-31 | $5,903,720 | 22,108 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $400,560 | 1,500 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $667,600 | 2,500 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $4,627,600 | 20,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $12,005,151 | 51,885 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,095,300 | 7,500 | Shares | Sole | 2023-11-14 | |
| 2020-12-31 | $347,962 | 3,130 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||